Recognition by macrophages and liver cells of opsonized phospholipid vesicles and phospholipid headgroups

Pharmaceutical Research

Volumn 18, Issue 1, 2001, Pages 1-8

  Moghimi, S M ^a   Hunter, A C ^a  

^a UNIVERSITY OF BRIGHTON   (United Kingdom)

Author keywords

Complement activation; Complement receptors; Kupffer cells; Liposomes; Macrophage; Opsonins; Phosphatidylserine; Scavenger receptors

Indexed keywords

APOLIPOPROTEIN; COMPLEMENT; COMPLEMENT RECEPTOR; FETUIN; IMMUNOGLOBULIN; LECTIN RECEPTOR; LIPOSOME; MEMBRANE RECEPTOR; PHOSPHOLIPID; PLASMA PROTEIN; SCAVENGER RECEPTOR; THROMBOSPONDIN; VON WILLEBRAND FACTOR;

COMPLEMENT ACTIVATION; LIVER CELL; MACROPHAGE; OPSONIZATION; PHAGOCYTOSIS; PHOSPHOLIPID VESICLE; PRIORITY JOURNAL; PROTEIN INTERACTION; RECEPTOR INTRINSIC ACTIVITY; REVIEW;

ANIMALS; BLOOD PROTEINS; HEPATOCYTES; HUMANS; LIPOSOMES; MACROPHAGES; OPSONIN PROTEINS; PHOSPHOLIPIDS; RECEPTORS, IMMUNOLOGIC;

EID: 0035045942     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011054123304     Document Type: Review

References (72)

1. Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo
2. Interactions of liposomes with serum proteins
3. Tissue specific opsonins for phagocytic cells and their different affinity for cholesterol-rich liposomes
4. Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes
5. The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes
6. Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes
7. Serum opsonins and liposomes: Their interaction and opsonophagocytosis
8. Antibodies to cholesterol, cholesterol conjugates and liposomes: Implications for atherosclerosis and autoimmunity
9. The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and β2 glycoprotein 1 (and other proteins)
10. Innovations in avoiding particles clearance from blood by Kupffer cells: Cause for reflection
11. Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system - The concept of tissue specificity
12. Immunohistochemical phenotyping of liver macrophages in normal and diseased human liver
13. The role of immunoproteins in the survival of liposomes in the circulation
14. The interaction of liposomes with the complement system
15. Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in fresh rat plasma
16. Liposome-induced activation of the classical complement pathway does not require immunoglobulin
17. Unusual electrostatic effects on binding of C1q to anionic liposomes: Role of anionic phospholipid domains and their line tension
18. Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids
19. Interactions of C-reactive protein and complement with liposomes
20. Liposome-complement interactions in rat serum: Implications for liposome survival studies
21. A novel type of binding specificity to phospholipids of rat mannose-binding proteins isolated from serum and liver
22. The human mannose-binding protein functions as an opsonin
23. Interaction of C-reactive protein with artificial phosphatidylcholine bilayers
24. Conformational epitopes of C3 reflecting its mode of binding to an artificial polymer surface
25. Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes
26. Identification of proteins mediating clearance of liposomes using a liver perfusion system
27. Chronic complement C3 gene expression in the CNS of transgeneic mice with astrocyte-targeted interleukin-6 expression
28. The binding of phosphatidylglycerol liposomes to rat platelets is mediated by complement
29. Structural and metabolic consequences of liposome-lipoprotein interactions
30. Mouse models of atherosclerosis
31. Receptor versus nonreceptor mediated clearance of liposomes
32. β2-glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of 'non-self' particles
33. Enhancing effect of cholesterol on the elimination of liposomes from circulation is mediated by complement activation
34. In vivo studies on the role of complement in the clearance of liposomes in rats and guinea pigs
35. Opsono-recognition of liposomes by tissue macrophages
36. Differential properties of organ-specific serum opsonins for liver and spleen macrophages
37. Calcium as a possible modulator of Kupffer cell phagocytic function by regulating liver-specific opsonic activity
38. Altered tissue-specific opsonic activities and opsono-recognition of liposomes in tumour-bearing rats
39. In vivo stability of ester- and ether-linked phospholipid-containing liposomes as measured by perturbed angular correlation spectroscopy
40. Effects of apolipoproteins A-IV and A-I on the uptake of phospholipid liposomes by hepatocytes
41. 2-HS-glycoprotein) opsonizes cationic macrophage-deactivating molecules
42. Enhanced IgG- and complement-independent phagocytosis of sulfatide-enriched human erythrocytes by human monocytes
43. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis
44. Serum independent liposome uptake by mouse liver
45. Co-existance of serum-dependent and serum-independent mechanism for liposome clearance and involvement of non-Kupffer cells in liposome uptake by mouse liver
46. Recognition of liposomes by cell: In vitro binding and endocytosis mediated by specific lipid head groups and surface charge density
47. Membrane molecules and macrophage endocytosis: Scavenger receptor and macrosialin as markers of plasma-membrane and vacuolar functions
48. Recent progress on defining the role of scavenger receptors in lipid transport, atherosclerosis and host defence
49. Collagenous macrophage scavenger receptors
50. The collagenous domains of macrophage scavenger receptors and complement component C1q mediate similar, but not identical, binding specificities for polyanionic ligands
51. Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages
52. Influence of liposome charge on the association of liposomes with Kupffer cells in vitro. Effects of divalent cations and competition with latex particles
53. Uptake of liposomes containing phosphatidylserine by liver cells in vivo and by sinusoidal liver cells in primary culture: In vivo-in vitro differences
54. Scavenger receptor-mediated uptake and metabolism of lipid vesicles containing acidic phospholipids by mouse peritoneal macrophages
55. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection
56. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages
57. CD36 is a receptor for oxidized low density lipoprotein
58. SRB1, a class B scavenger receptor, recognizes both negatively charged liposomes and apoptotic cells
59. Scavenger receptor B1 (SR-B1) substrates inhibit the selective uptake of high-density-lipoprotein cholesteryl esters by rat parenchymal liver cells
60. High affinity saturable uptake of oxidized low density lipoprotein by macrophages from mice lacking the scavenger class A type I/II
61. Characterization of a receptor for oxidized low-density lipoproteins on rat Kupffer cells: Similarity to macrosialin
62. An endothelial receptor for oxidized low-density lipoprotein
63. Expression cloning of a novel scavenger receptor from human endothelial cells
64. Rat liver Kupffer and endothelial cells express different binding proteins for modified low density lipoproteins
65. Enhanced expression of endothelial oxidized low-density lipoprotein receptor (LOX-1) in hypertensive rats
66. In vivo detection and imaging of phosphatidylserine expression during programmed cell death
67. Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells
68. A macrophage Fc receptor for IgG is also a receptor for oxidized low-density-lipoprotein
69. Multiple receptors for modified low-density lipoproteins in mouse peritoneal-macrophages. Different uptake mechanisms for acetylated and oxidized low-density lipoproteins
70. Human CD14 mediates recognition and phagocytosis of apoptotic cells
71. Hormonal-control of macrophage phagocytosis of phospholipid vesicles
72. Fibronectin-enhanced phagocytosis of an alternative pathway activator by human culture-derived macrophages is mediated by the C4B/C3B complement receptor (CR-1)